In Toyota Leadership Lessons: You have to let the person you are helping to explore ideas and fail.
Learn More Brii Biosciences is committed to bringing innovative medicines to China as a way to improve public health. We bring together clinically differentiated assets to meet this challenge, supported by world-class leadership, advisors, partners, and funders.
The pace of innovation has accelerated over the past decade, resulting in dramatically better treatments and cures for life-threatening diseases. Unfortunately, these innovations have not always reached China or the patients in China who need them. Breakthroughs in science and technology, and advances in digital and data capabilities, are poised to disrupt the discovery, development and delivery of medicines.
At the same time, the regulatory environment in China has improved significantly. Leadership Team The Brii Bio leadership team includes industry-leading scientists with a strong track record of discovering and developing novel medicines.
Prior to starting Brii Bio, Dr. GSK now has one of the most innovative pipelines against infectious diseases. Hong is a public health advocate who has helped establish multiple public-private partnerships with the U. Hong started Ardea Biosciences later acquired by AstraZeneca.
Hong has more than 25 years of experience in drug discovery and development and has brought more than 30 compounds into development, including many that have been approved and launched.
He is accountable for developing and driving execution of clinical development programs and registrations in China. Prior to joining the company, Dr. Yan was Vice President and Head Unit Physician of GSK Oncology, where he oversaw global development of oncology assets focusing on immunotherapy, cancer epigenetics, and cell therapy.
Prior to his tenure at GSK, he was Executive Director at Merck responsible for clinical development of oncology, respiratory and immunology, infectious diseases, and vaccines in emerging markets. He has published over 80 manuscripts and book chapters. He is also an alumnus of the Harvard Business School enterprise executive program.
Xu had an illustrious career at Gilead Sciences where she was a senior director, a co-inventor of several successful antiviral therapies, and led the discovery efforts in many therapeutic areas against HIV, HCV, HBV, and cancers resulting in numerous clinical candidates.
Prior to Gilead, Dr. Xu worked at Abbott Laboratories now AbbVie in the fields of anti-inflammatory and anti-cancer research.
Xu holds a B. She has co-authored more than 30 peer-reviewed scientific publications and holds more than 30 issued patents and applications. Girardet served as Vice President, Pharmaceutical and Translational Sciences at Ardea Biosciences, a member of the AstraZeneca Group, where he led the progression of Ardea's internal discovery programs from concept to clinical development, and eventually to approval.
Girardet assisted the business development group in the sale of Ardea Biosciences to AstraZeneca, and in the successful licensing of refametinib to Bayer Healthcare.View Notes - Case Chapter 5, McKinsey from ECON at Erusmus University Rotterdam. McKinsey & Company: Managing Knowledge and Learning The Founder`s Legacy - founded in by University of%(15).
McKinsey & Company: Managing Knowledge and Learning Evaluating Gupta’s Four Pronged Plan Rajat Gupta has recently inherited a fast-growing consulting firm with a strong knowledge base and a competitive market position.
Knowledge Unplugged announces the results of a major survey of knowledge management practice within the most influential companies in the world, by the most influential management consultancy group in the world.
The McKinsey Knowledge Management team interviewed top executives and also investigated how far their plans were implemented in practice, in 40 companies in the US, Europe and . The programme’s key objective is to stimulate new research avenues in the field of archaeology, relying on the comparison, re-use and integration into current research, the outcomes of past and on-going field and laboratory activity.
McKinsey & Company is an American worldwide management consulting firm. It conducts qualitative and quantitative analysis to evaluate management decisions across public and private sectors.
McKinsey publishes the McKinsey Quarterly since , funds the McKinsey Global Institute research organization, publishes reports on management topics, and has authored many influential books on . Further Learning Resources. UPDATE 4 November We like these articles Moving from a Training Culture to a Learning Culture, Build an effective L&D culture and The differences between learning in an e-business and learning in a social business (and the emphasis on ‘connect and collaborate’ learning rather than the traditional ‘command and control’ teaching).